Case number 1:18-cv-01900
Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 21, 2020 | 20 | Patent/Trademark Report to Commissioner (5) Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl) |
| Oct 7, 2020 | 19 | Order (4) Docket Text: CONSENT JUDGMENT AND ORDER OF PERMANENT INJUNCTION, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 10/5/20. Associated Cases: 1:18-cv-00300-LPS-CJB, 1:18-cv-01900-LPS-CJB, 1:19-cv-00876-LPS-CJB (ntl) |
| Oct 21, 2019 | N/A | Remark (0) Docket Text: REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience: http://www.ded.uscourts.gov/sites/default/files/forms/StandingOrder2017.pdf (dlb) |
| Aug 16, 2019 | 18 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to amend Judge Burke's August 6, 2018 Oral Order to August 21, 2019 - filed by Teva Pharmaceuticals USA Inc., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| May 28, 2019 | 17 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Said Saim and Dr. Ravi K. Varanasi on June 25 and June 26 at 9:00 a.m. filed by Teva Pharmaceuticals USA Inc., Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jan 29, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. (48 in 1:18-cv-00300-LPS-CJB, 16 in 1:18-cv-01900-LPS-CJB) Stipulation to Consolidate Actions filed by Teva Pharmaceuticals USA Inc., Teva Pharmaceuticals USA, Inc. Ordered by Judge Christopher J. Burke on 1/29/2019. Associated Cases: 1:18-cv-01900-LPS-CJB, 1:18-cv-00300-LPS-CJB(dlb) |
| Jan 29, 2019 | N/A | Remark (0) Docket Text: Remark: Civil action 18-cv-0300-LPS-CJB has been designated as the lead case. All future documents shall be filed in the lead case only. (dlb) |
| Jan 29, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: 1:18-cv-00300-LPS-CJB. (dlb) |
| Jan 28, 2019 | 16 | Stipulation (3) Docket Text: STIPULATION (and Proposed Order) to Consolidate Actions by Teva Pharmaceuticals USA Inc., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Jan 25, 2019 | 15 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Preliminary Infringement Contentions filed by Collegium Pharmaceutical, Inc..(Haynes, Christine) |
| Jan 24, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Kelsey J. Thorkelson and Jake M. Holdreith for Collegium Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
| Jan 24, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Oren D. Langer for Collegium Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
| Jan 22, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jonathan D. Ball,Richard C. Pettus for Teva Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Jan 18, 2019 | 14 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard C. Pettus and Jonathan D. Ball, Ph.D. - filed by Teva Pharmaceuticals USA Inc., Teva Pharmaceuticals USA, Inc.. Motions referred to Christopher J. Burke.(Keller, Karen) |
| Jan 18, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. (14 in 1:18-cv-01900-LPS-CJB, 45 in 1:18-cv-00300-LPS-CJB) MOTION for Pro Hac Vice Appearance of Attorney Richard C. Pettus and Jonathan D. Ball, Ph.D. filed by Teva Pharmaceuticals USA Inc., Teva Pharmaceuticals USA, Inc. Ordered by Judge Christopher J. Burke on 1/18/2019. Associated Cases: 1:18-cv-00300-LPS-CJB, 1:18-cv-01900-LPS-CJB(dlb) |
| Jan 18, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [13] MOTION for Pro Hac Vice Appearance of Attorney Jake M. Holdreith, Oren D. Langer and Kelsey J. Thorkelson of Robins Kaplin LLP filed by Collegium Pharmaceutical, Inc. Ordered by Judge Christopher J. Burke on 1/18/2019. (dlb) |
| Jan 16, 2019 | 13 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jake M. Holdreith, Oren D. Langer and Kelsey J. Thorkelson of Robins Kaplin LLP - filed by Collegium Pharmaceutical, Inc.. Motions referred to Christopher J. Burke.(Cottrell, Frederick) |
| Jan 14, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Chief Judge Stark's Case Management Checklist ("Checklist"). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (i) a copy of the "Checklist" indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order (consistent with the Chief Judge Stark's Revised Patent Form Scheduling Order); and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding the disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties' review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court will schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Stark and/or Judge Burke. The Checklist and Revised Patent Form Scheduling Order can be found on this Court's website (www.ded.uscourts.gov/judge/chief-judge-leonard-p-stark). Ordered by Judge Christopher J. Burke on 1/14/2019. (dlb) |
| Jan 11, 2019 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA Inc. filed by Teva Pharmaceuticals USA Inc.. (Shaw, John) |
| Jan 11, 2019 | 11 | Answer to Complaint (26) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Collegium Pharmaceutical, Inc. by Teva Pharmaceuticals USA Inc..(Shaw, John) |
| Jan 10, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Richard Mills-Robertson for Teva Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Jan 9, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [10] MOTION for Pro Hac Vice Appearance of Attorney Richard Mills-Robertson filed by Teva Pharmaceuticals USA Inc. Ordered by Judge Christopher J. Burke on 1/9/2019. (mlc) |
| Jan 8, 2019 | 10 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard Mills-Robertson - filed by Teva Pharmaceuticals USA Inc.. Motions referred to Christopher J. Burke.(Keller, Karen) |
| Jan 7, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Brooke E. Hazan, Allan A. Kassenoff, Cort Welch, Douglas R. Weider, Jonathan R. Wise, and Scott J. Bornstein for Teva Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
| Jan 4, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [9] MOTION for Pro Hac Vice Appearance of Attorney Scott J. Bornstein, Allan A. Kassenoff, Brooke E. Hazan, Cort Welch, Douglas R. Weider, and Jonathan Wise filed by Teva Pharmaceuticals USA Inc. Ordered by Judge Christopher J. Burke on 1/4/2019. (mlc) |
| Jan 3, 2019 | 9 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Scott J. Bornstein, Allan A. Kassenoff, Brooke E. Hazan, Cort Welch, Douglas R. Weider, and Jonathan Wise - filed by Teva Pharmaceuticals USA Inc.. Motions referred to Christopher J. Burke.(Keller, Karen) |
| Dec 21, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [8] STIPULATION TO EXTEND TIME to Respond to the Complaint to January 11, 2019 filed by Teva Pharmaceuticals USA Inc. Ordered by Judge Christopher J. Burke on 12/21/2018. (dlb) |
| Dec 20, 2018 | 8 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to January 11, 2019 - filed by Teva Pharmaceuticals USA Inc.. (Keller, Karen) |
| Dec 10, 2018 | N/A | Order Referring Case to Magistrate Judge (0) Docket Text: ORAL ORDER REFERRING CASE to Magistrate Judge Christopher J. Burke: IT IS HEREBY ORDERED that the above captioned case is referred to Magistrate Judge Christopher J. Burke to hear and resolve all pretrial matters, up to and including the resolution of case-dispositive motions, subject to 28 U.S.C. ยง 636(b) and any further Order of the Court; all subsequent filings in this action shall be captioned as follows: Civil Action No. 18-1900-LPS-CJB. ORDERED by Judge Leonard P. Stark on 12/10/18. (ntl) |
| Dec 6, 2018 | 6 | Exhibit A (2) |
| Dec 6, 2018 | 6 | Affidavit of Service (3) Docket Text: AFFIDAVIT of Service for Complaint served on Karen E. Keller, Esquire on behalf of Teva Pharmaceuticals USA, Inc. on December 5, 2018, filed by Collegium Pharmaceutical, Inc.. (Attachments: # (1) Exhibit A)(Haynes, Christine) |
| Dec 6, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Nov 30, 2018 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (ceg) |
| Nov 30, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Collegium Pharmaceutical, Inc. (ceg) |
| Nov 30, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,968,598; 10,004,729. (ceg) |
| Nov 30, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/19/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 7/10/2020. (ceg) |
| Nov 30, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Nov 30, 2018 | 1 | Civil Cover Sheet (1) |
| Nov 30, 2018 | 1 | Exhibits A-B (48) |
| Nov 30, 2018 | 1 | Complaint* (1) |
